Sebastian Anastassiou serves as a Board Member at Connective Health since September 2024 and holds the position of Principal and Head of Investments at Nina Capital since June 2020, focusing on investments in health tech innovators. Additionally, Sebastian is a Board Member at Segmed, Inc., EarlySight, and Terapet SA, and acts as a Board Observer for Promptly Health and contextflow. With extensive experience in the health tech sector, Sebastian has contributed to organizations developing innovative solutions, from medical AI to retinal imaging and proton therapy. An accomplished academic, Sebastian earned an MBA from IESE Business School with a concentration in Entrepreneurship & Innovation, a Master of Science in Management of Bioeconomy, Innovation and Governance from The University of Edinburgh, and a Bachelor of Science in Neuroscience from the same institution.
This person is not in any teams
Nina Capital
We have a vision for the future in which data, computing, networks, and other digital and deep technologies deliver meaningful outcomes and insight for improving health and the provision of care. We believe the creation of new businesses is built on in-depth understanding of the complex network of healthcare system participants, and marrying that with meaningful engineering innovation, advanced data science, and information technology-enabled products and services. We look for and seed founders determined to effectively and efficiently serve these participants on the european continent and internationally. We are committed to addressing needs across the care continuum, healthcare systems, and all specialties.